NCT03473093

Brief Summary

Determine the effect of using oral pregabalin on the analgesic effects of IV infusion of morphine in patients with multiple fracture ribs.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Mar 2018

Shorter than P25 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 22, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

March 23, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

March 8, 2018

Last Update Submit

March 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • decrease pain

    measured by visual analogue score ranged from 0 to 10 with higher numbers are worse than lower numbers

    one week

Secondary Outcomes (1)

  • I.C.U stay time

    one week

Study Arms (2)

morphine

ACTIVE COMPARATOR

This group will receive only morphine infusion (20microgram/kg/h)

Drug: Morphine

pregabalin

ACTIVE COMPARATOR

This group will receive only morphine infusion (20microgram/kg/h) and oral pregabalin (150 mg)

Drug: Pregabalin 150mgDrug: Morphine

Interventions

One group will receive oral pregabalin with morphine infusion

pregabalin

One group will receive morphine infusion 20 microgram/kg/h

morphinepregabalin

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients above 18 years old
  • ASA \[1\] and ASA \[2\]
  • mentally competent and able to give consent for enrollment in the study

You may not qualify if:

  • Patient coma scale less than 10
  • Impaired kidney functions
  • Chronic pain syndromes and patients with chronic opioid use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Cannon RM, Smith JW, Franklin GA, Harbrecht BG, Miller FB, Richardson JD. Flail chest injury: are we making any progress? Am Surg. 2012 Apr;78(4):398-402.

    PMID: 22472394BACKGROUND
  • Katz J, Jackson M, Kavanagh BP, Sandler AN. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain. 1996 Mar;12(1):50-5. doi: 10.1097/00002508-199603000-00009.

    PMID: 8722735BACKGROUND
  • Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986 Oct;27(1):117-126. doi: 10.1016/0304-3959(86)90228-9.

    PMID: 3785962BACKGROUND

MeSH Terms

Conditions

Fractures, Bone

Interventions

PregabalinMorphine

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

gamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and ProteinsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Central Study Contacts

khaled mohamad morsy, PhD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 8, 2018

First Posted

March 22, 2018

Study Start

March 1, 2018

Primary Completion

March 1, 2019

Study Completion

April 1, 2019

Last Updated

March 23, 2018

Record last verified: 2018-03